CoChat

The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis

van Hal, S. J., Lodise, T. P., Paterson, D. L. · 2012 · Clinical Infectious Diseases

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Emerging data suggest that vancomycin may be less effective against serious methicillin-resistant Staphylococcus aureus (MRSA) infections with minimum inhibitory concentration (MIC) values at the higher end of the susceptibility range. The purpose of this review is to examine the strength of these associations. METHODS: All relevant studies pertaining to treatment outcomes or mortality associated with vancomycin MIC were retrieved from the medical literature from January 1996 through August 2011 and analyzed according to Cochrane guidelines. RESULTS: Of the 270 studies identified, 48 studies were reviewed, with 22 studies included in the final meta-analysis. Vancomycin MIC was significantly associated with mortality for MRSA infection irrespective of the source of infection or MIC methodology (odds ratio [OR], 1.64; 95% confidence interval [CI], 1.14-2.37; P < .01). This mortality association was predominantly driven by bloodstream infections (BSIs; OR, 1.58; 95% CI, 1.06-2.37; P = .03) and isolates with a vancomycin MIC of 2 μg/mL by Etest (OR, 1.72; 95% CI, 1.34-2.21; P < .01). Vancomycin MIC was significantly associated with treatment failure irrespective of source of infection or MIC methodology (OR, 2.69; 95% CI, 1.60-4.51; P < .01). CONCLUSION: High vancomycin MIC was associated with a higher mortality rate in MRSA BSI. Thus, institutions should consider conducting Etest MICs on all MRSA BSI isolates. Although these data highlight concerns about vancomycin, currently, there are no data to support better survival rates with alternative antibiotics. Data are sorely needed to determine whether other agents can remedy these outcomes observed with vancomycin for MRSA infections with elevated vancomycin MIC values.

Overview

Integrity signals

Registry

Crossref · 10.1093/cid/cir935

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 69 references

Research works printed but not linked: 3

  1. 2003, MMWR. Morbidity and mortality weekly report, 52, 992
  2. 2001, MMWR. Morbidity and mortality weekly report, 50, 919
  3. 2011, S D MED, 64, 91

Cited by

See all 512

Metadata

Authors
van Hal, S. J., Lodise, T. P., & Paterson, D. L.
Affiliations
  • Albany College of Pharmacy and Health Sciences (US)
  • The University of Queensland (AU)
Venue
Clinical Infectious Diseases
Published
2012-02-02
Volume
54
Issue
6
Pages
755-771
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2135788092
Cited by
512
References
69
Citations by year
2026: 4 · 2025: 10 · 2024: 17 · 2023: 15 · 2022: 24 · 2021: 27 · 2020: 32 · 2019: 32 · 2018: 32 · 2017: 32 · 2016: 39 · 2015: 59 · 2014: 73 · 2013: 84 · 2012: 29
FWCI
9.72
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • Gilead Sciences
  • Astellas Pharma
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords
vancomycin, minimum inhibitory concentration, methicillin-resistant Staphylococcus aureus, bloodstream infection, mortality, treatment failure, E-test, antibiotic susceptibility, vancomycin resistance
MeSH terms
Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Vancomycin, Treatment Failure, Sepsis, Vancomycin Resistance, Methicillin-Resistant Staphylococcus aureus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis. https://app.cochat.ai/papers/10.1093/cid/cir935
The paper
van Hal, S. J., Lodise, T. P., & Paterson, D. L. (2012). The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cir935

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.